The diagnostic value to meylodysplastic syndrome by using enzyme labeling of micromegakaryocytes in bone marrow biopsy

LI Ping
DOI: https://doi.org/10.14163/j.cnki.11-5547/r.2012.31.098
2012-01-01
Abstract:Objective Using of bone marrow biopsy of small megakaryocytes with enzyme labeling staining to detect myelodysplastic syndrome(MDS) patients' micromegakaryocytes(SMK) condition,so as to judge the diagnoise value of bone marrow biopsy of small megakaryocytes enzyme staining in patients with MDS.Methods To detect small megakaryocytes condition on 52 cases in our hospital diagnosed as MDS patients with bone marrow smear and bone marrow biopsy of megakaryocyte specific antibodies(CD41a) labeled with alkaline phosphatase antialkaline phosphatase(APAAP) method for staining of bone marrow smear and with conventional staining method.Results 18 cases of 52 cases of MDS patients' bone marrow with smear staining method detect of micromegakaryocytes,the pnositive rate was 34.6%,0 cases with lymphoid small megakaryocytes,the positive rate was 0.30 cases of 52 cases using bone marrow smear combined with APAAP method detect of micromegakaryocytes,the positive rate was 57.7%,22 cases with lymphoid small megakaryocytes,the positive rate was 42.3%.48 cases of 52 cases using bone marrow biopsy combined with APAAP method detect of micromegakaryocytes,the positive rate was 92.3%,47 cases with lymphoid small megakaryocytes,the positive rate was 90.4%.Compared the three methods for detection of micromegakaryocytes' positive rate wiith Chi square test,there was a statistically significant difference between them(P<0.05).Compared the three methods for detection of lymphoid micromegakaryocyte positive's rate with Chi square test,P< 0.05,there was a statistically significant difference between the three methods(P< 0.05).We can see,bone marrow biopsy enzyme staining method for detection of micromegakaryocytes positive's rate and lymphoid micromegakaryocyte positive's rate is the highest.Conclusion Using of bone marrow biopsy for small megakaryocytes enzyme labeling staining can detect of micromegakaryocytes and lymphoid small megakaryocytes much more accurated,and can visually display the megakaryocyte morbid hematopoietic distribution,and provides reliable basis for early diagnosis of MDS.
What problem does this paper attempt to address?